James M. Swanson

Q: What Schools Are Affiliated With James M. Swanson

James M. Swanson is affiliated with the following schools: McGill University, University of California, Irvine, Florida International University

James M. Swanson's AcademicInfluence.com Rankings

James M. Swanson

Psychology

#2414

World Rank

#2803

Historical Rank

Clinical Psychology

#184

World Rank

#187

Historical Rank

psychology Degrees

Download Badge

Psychology

Why Is James M. Swanson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

James M. Swanson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. (1999) (3124)
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications (2004) (1167)
The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. (2009) (1130)
Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. (2001) (1024)
ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. (2001) (935)
Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. (2009) (803)
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. (1996) (723)
3-year follow-up of the NIMH MTA study. (2007) (625)
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. (1999) (606)
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. (2016) (595)
Etiologic Subtypes of Attention-Deficit/Hyperactivity Disorder: Brain Imaging, Molecular Genetic and Environmental Factors and the Dopamine Hypothesis (2007) (576)
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers (2001) (562)
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. (2004) (561)
Evaluating dopamine reward pathway in ADHD: clinical implications. (2009) (491)
Evidence of positive selection acting at the human dopamine receptor D4 gene locus (2001) (489)
Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. (2003) (443)
Dopamine genes and ADHD (2000) (429)
Symptom profiles in children with ADHD: effects of comorbidity and gender. (2001) (426)
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. (2006) (414)
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. (2006) (409)
Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach (1998) (406)
The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. (2004) (396)
Exposure to appetitive food stimuli markedly activates the human brain (2004) (394)
Parent and Teacher SNAP-IV Ratings of Attention Deficit Hyperactivity Disorder Symptoms (2008) (387)
Observed Classroom Behavior of Children with ADHD: Relationship to Gender and Comorbidity (2002) (374)
Self-perceptions of competence in children with ADHD and comparison children. (2004) (367)
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. (2007) (362)
Assessing the molecular genetics of attention networks (2002) (355)
Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. (2012) (353)
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. (2004) (351)
Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway (2010) (343)
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. (2007) (320)
Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. (2007) (319)
Effect of Stimulant Medication on Children with Attention Deficit Disorder: A “Review of Reviews” (1993) (308)
Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications (2002) (304)
Activation of Orbital and Medial Prefrontal Cortex by Methylphenidate in Cocaine-Addicted Subjects But Not in Controls: Relevance to Addiction (2005) (304)
NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. (1995) (290)
Expectation Enhances the Regional Brain Metabolic and the Reinforcing Effects of Stimulants in Cocaine Abusers (2003) (290)
Family Processes and Treatment Outcome in the MTA: Negative/Ineffective Parenting Practices in Relation to Multimodal Treatment (2000) (287)
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. (1996) (287)
Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder (1998) (284)
Cognitive control of drug craving inhibits brain reward regions in cocaine abusers (2010) (284)
Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. (2001) (284)
Which treatment for whom for ADHD? Moderators of treatment response in the MTA. (2003) (283)
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. (1999) (279)
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. (2001) (277)
Behavioral versus Behavioral and Pharmacological Treatment in ADHD Children Attending a Summer Treatment Program (2000) (268)
Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. (2000) (267)
Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. (2004) (265)
Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder (2005) (265)
Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale – parent form (2008) (259)
Reaction Time Distribution Analysis of Neuropsychological Performance in an ADHD Sample (2006) (259)
Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. (2016) (255)
Patterns of memory loss in three elderly samples. (1987) (255)
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. (1997) (249)
Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA) (2000) (247)
Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. (2003) (246)
Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress (2011) (245)
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) (242)
Brain dopamine transporter levels in treatment and drug naïve adults with ADHD (2007) (239)
Parenting and Family Stress Treatment Outcomes in Attention Deficit Hyperactivity Disorder (ADHD): An Empirical Analysis in the MTA Study (2000) (238)
Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA. (2016) (234)
Safety and tolerability of methylphenidate in preschool children with ADHD. (2006) (232)
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). (2004) (231)
Parent Cognitions as Predictors of Child Treatment Response in Attention-Deficit/Hyperactivity Disorder (2000) (231)
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. (2013) (226)
Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. (2007) (224)
Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. (2016) (212)
Stimulant Medications and the Treatment of Children with ADHD (1995) (211)
A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. (2007) (207)
Stimulant-related reductions of growth rates in the PATS. (2006) (206)
Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. (1978) (204)
Methylphenidate-Elicited Dopamine Increases in Ventral Striatum Are Associated with Long-Term Symptom Improvement in Adults with Attention Deficit Hyperactivity Disorder (2012) (202)
Activating Tasks for the Study of Visual-Spatial Attention in ADHD Children: A Cognitive Anatomic Approach (1991) (201)
Analog classroom assessment of Adderall in children with ADHD. (1998) (201)
Psychosocial Treatment Strategies in the MTA Study: Rationale, Methods, and Critical Issues in Design and Implementation (2000) (200)
Developmental origins of health and disease: environmental exposures. (2009) (193)
Young adult outcomes in the follow‐up of the multimodal treatment study of attention‐deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression (2017) (191)
Food dyes impair performance of hyperactive children on a laboratory learning test. (1980) (189)
High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder (2003) (183)
The Effect of Methylphenidate on Three Forms of Response Inhibition in Boys with AD/HD (2003) (179)
The National Children's Study: A 21-Year Prospective Study of 100 000 American Children (2006) (177)
Functional connectivity of frontal cortex in healthy and ADHD children reflected in EEG coherence. (2007) (173)
Serum and brain concentrations of methylphenidate: implications for use and abuse (2003) (173)
Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD (2002) (170)
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. (2001) (169)
A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. (2002) (167)
Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: Psychometric properties and normative ratings from a school district sample (2011) (165)
Fetal Programming of Body Composition, Obesity, and Metabolic Function: The Role of Intrauterine Stress and Stress Biology (2012) (164)
Compliance with Stimulants for Attention-Deficit/Hyperactivity Disorder (2003) (163)
Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. (2005) (160)
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. (2003) (154)
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. (2003) (152)
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. (2003) (149)
Clinical practice: Adult attention deficit-hyperactivity disorder. (2013) (145)
Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. (2007) (144)
ADHD with Comorbid Disorders: Clinical Assessment and Management (1999) (143)
Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (141)
Stimulant-related state-dependent learning in hyperactive children. (1976) (141)
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. (2000) (141)
Reliability and validity of the SKAMP rating scale in a laboratory school setting. (1998) (140)
Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity (2017) (138)
Assessing medication effects in the MTA study using neuropsychological outcomes. (2006) (137)
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). (2006) (136)
A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. (2006) (135)
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in The Multimodal Treatment Study of Children With ADHD: Developmental cascades and vicious cycles (2010) (133)
Patterns and Predictors of Adolescent Academic Achievement and Performance in a Sample of Children with Attention-Deficit/Hyperactivity Disorder (2011) (132)
Effects of Stimulant Medication on Learning in Children with ADHD (1991) (132)
Efficacy and Safety of Modafinil Film–Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study (2005) (132)
Covert visual spatial attention in boys with attention deficit hyperactivity disorder: Lateral effects, methylphenidate response and results for parents (1997) (130)
A Twin Study of Attention-Deficit/Hyperactivity Disorder Dimensions Rated by the Strengths and Weaknesses of ADHD-Symptoms and Normal-Behavior (SWAN) Scale (2007) (129)
Naloxone attenuates self-abusive behavior in developmentally disabled clients. (1983) (128)
Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder (2013) (128)
More frequent diagnosis of attention deficit-hyperactivity disorder. (1995) (124)
Pharmacogenetics of methylphenidate response in preschoolers with ADHD. (2006) (123)
Maternal Depressive Symptomatology and Parenting Behavior: Exploration of Possible Mediators (2007) (123)
The services for children and adolescents-parent interview: development and performance characteristics. (2004) (119)
Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects. (1983) (118)
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment (2018) (118)
Impaired Executive Function Mediates the Association between Maternal Pre-Pregnancy Body Mass Index and Child ADHD Symptoms (2012) (117)
Socioeconomic status as a moderator of ADHD treatment outcomes. (2002) (116)
Genes and attention-deficit hyperactivity disorder (2001) (114)
Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. (2003) (112)
Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (111)
Timing, Space and ADHD: The Dopamine Theory Revisited (2001) (110)
Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. (2006) (110)
Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. (2006) (108)
Overrepresentation of adoptees in children with the attention deficit disorder (1982) (108)
Case study: adverse response to clonidine. (1997) (104)
Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. (2017) (104)
Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. (2000) (104)
Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. (1983) (103)
Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. (2009) (103)
Subtypes versus severity differences in attention-deficit/hyperactivity disorder in the Northern Finnish Birth Cohort. (2007) (103)
Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) (2008) (102)
Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task (2008) (101)
Combining methylphenidate and clonidine: a clinically sound medication option. (1999) (99)
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. (2000) (98)
Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. (2002) (97)
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma (2003) (95)
Familial Aggregation of ADHD Characteristics (2000) (95)
Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects (2006) (93)
Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA) (2008) (92)
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. (2004) (91)
Hemispheric Processing and Methylphenidate Effects in Attention-Deficit Hyperactivity Disorder (1994) (90)
Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. (2012) (88)
Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder. (1997) (87)
Clonidine in the Treatment of ADHD: Questions about Safety and Efficacy (1995) (87)
Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention‐deficit/hyperactivity disorder (ADHD): Increased prevalence of the 2‐repeat allele (2005) (87)
NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution (1997) (86)
Life Span Studies of ADHD—Conceptual Challenges and Predictors of Persistence and Outcome (2016) (86)
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (85)
Attention-deficit/hyperactivity disorder: Symptom domains, cognitive processes, and neural networks. (1998) (85)
The Role of Stress in Brain Development: The Gestational Environment’s Long-Term Effects on the Brain (2012) (84)
Genetic latent structure analysis of dysmorphology in attention deficit disorder. (1990) (83)
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (83)
Exploring the associations between microRNA expression profiles and environmental pollutants in human placenta from the National Children's Study (NCS) (2015) (82)
Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/Hyperactivity Disorder (2002) (81)
The UK Biobank and selection bias (2012) (81)
Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. (1998) (80)
Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. (1999) (80)
Catecholamine Response to Exercise in Children with Attention Deficit Hyperactivity Disorder (2003) (80)
Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, Version IV Scale-Teacher Form. (2009) (78)
The Reliability and Validity of the English and Spanish Strengths and Weaknesses of ADHD and Normal Behavior Rating Scales in a Preschool Sample (2012) (76)
Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. (1995) (76)
Family factors associated with aggressive symptomatology in boys with attention deficit hyperactivity disorder: a research note. (1990) (75)
Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. (2003) (75)
Developmental origins of child mental health disorders. (2008) (75)
Substance use through adolescence into early adulthood after childhood‐diagnosed ADHD: findings from the MTA longitudinal study (2018) (75)
Parent-Reported Homework Problems in the MTA Study: Evidence for Sustained Improvement with Behavioral Treatment (2010) (74)
Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention- (2004) (73)
Psychopharmacology: concepts and opinions about the use of stimulant medications. (2009) (72)
Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? (2008) (70)
Information processing as a function of speed versus accuracy (1969) (69)
Methylphenidate hydrochloride given with or before breakfast (1983) (69)
Mutations in ECEL1 cause distal arthrogryposis type 5D. (2013) (68)
Natural social behaviors in hyperactive children: dose effects of methylphenidate. (1987) (68)
Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control. (2009) (67)
Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS) (2007) (67)
Impact of ADHD and cannabis use on executive functioning in young adults. (2013) (67)
Visual Perception Dominance of Fallers Among Community‐dwelling Older Adults (1985) (67)
Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial. (2004) (67)
Role of executive function in ADHD. (2003) (67)
Anxiolytics, adrenergic agents, and naltrexone. (1999) (67)
Evaluating Dopamine Reward Pathway in ADHD (2011) (66)
Stimulant medications for the treatment of ADHD: Efficacy and limitations (1999) (66)
Brown Adipose Tissue Quantification in Human Neonates Using Water-Fat Separated MRI (2013) (65)
Parent Agreement on Ratings of Children’s Attention Deficit/Hyperactivity Disorder and Broadband Externalizing Behaviors (2010) (65)
Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. (2007) (64)
Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment (2009) (64)
Parental Agreement on ADHD Symptom-Specific and Broadband Externalizing Ratings of Child Behavior. (2010) (63)
Treatment for ADHD: is more complex treatment cost-effective for more complex cases? (2007) (63)
Attentional Phenotypes for the Analysis of Higher Mental Function (2002) (62)
Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. (2007) (62)
Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA. (2016) (61)
Effects of Methylphenidate on Impulsive Responding in Children With Attention-Deficit Hyperactivity Disorder (1993) (59)
The Cognitive Effects of Stimulant Drugs on Hyperactive Children (1979) (58)
A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. (2006) (58)
Encoding, decoding, and central functions in human information processing (1970) (57)
Chronic Treatment with Extended Release Methylphenidate Does Not Alter Dopamine Systems or Increase Vulnerability for Cocaine Self-Administration: A Study in Nonhuman Primates (2012) (57)
The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications (2002) (57)
Hyperactive children's underuse of learning time: correction by stimulant treatment. (1977) (54)
Erythrosin B inhibition of neurotransmitter accumulation by rat brain homogenate. (1979) (53)
Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (53)
Neuropsychological and Psychophyioslogical Differentiation of Inattention/Overactivty and Aggression/Defiance Symptom Groups (1993) (52)
Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD. (2021) (52)
Increasing use of stimulants warns of potential abuse (2008) (51)
Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. (1988) (51)
Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia. (2013) (51)
Nine Months of Multicomponent Behavioral Treatment for ADHD and Effectiveness of MTA Fading Procedures (2004) (50)
ADHD in context: Young adults' reports of the impact of occupational environment on the manifestation of ADHD. (2016) (49)
Auditory attention in hyperactive children: effects of stimulant medication on dichotic listening performance. (1979) (48)
A divided attention analysis of the effects of methylphenidate on the arithmetic performance of children with attention-deficit hyperactivity disorder. (1991) (48)
Sequence variants of the DRD4 gene in autism: Further evidence that rare DRD4 7R haplotypes are ADHD specific (2005) (48)
Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: Preliminary indications from a secondary analysis of the COMACS study data (2004) (47)
A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. (2003) (46)
Relation Between Outcomes on a Continuous Performance Test and ADHD Symptoms Over Time (2011) (45)
Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah (2011). (2011) (45)
Child and Parent Predictors of Perceptions of Parent—Child Relationship Quality (2007) (43)
Biological bases of ADHD--Neuroanatomy, genetics, and pathophysiology. (2002) (43)
Appendix 5 – Chapter 2 The SNAP-IV Teacher and Parent Rating Scale (2003) (43)
Gas chromatographic/mass spectrometric analysis of methylphenidate (ritalin) in serum. (1980) (42)
The impact of an intensive multisensory reading program on a population of learning-disabled delinquents (1992) (41)
Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA). (2017) (40)
Lateralized attentional deficits in drug-free and medicated schizophrenic patients (1997) (40)
Progression of impairment in adolescents with attention-deficit/hyperactivity disorder through the transition out of high school: Contributions of parent involvement and college attendance. (2016) (39)
Diverse Perceptions of the Informed Consent Process: Implications for the Recruitment and Participation of Diverse Communities in the National Children’s Study (2012) (39)
Lateralized deficits in visual attention in males with developmental dopamine depletion (1992) (38)
Differential Effects of Stimulant Medication on Reading Performance of Boys With Hyperactivity With and Without Conduct Disorder (1991) (36)
The Reliability and Validity of the English and Spanish Strengths and Weaknesses of ADHD and Normal Behavior Rating Scales in a Preschool Sample: Continuum Measures of Hyperactivity and Inattention (2013) (35)
Prevalence and Characteristics of School Services for High School Students with Attention-Deficit/Hyperactivity Disorder (2014) (35)
Chapter 20 Attention and Hyperactivity (1990) (35)
Evaluation of individual subjects in the analog classroom setting: I. Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate. (1998) (35)
Stimulant Medication and Reading Performance (1992) (34)
Classroom Instructional Characteristics in Attention Deficit Hyperactivity Disorder: Comparison of Pure and Mixed Subgroups (1992) (34)
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior (2015) (34)
Methylphenidate increases selectivity of visual scanning in children referred for hyperactivity (1982) (33)
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task (2015) (33)
Late-Onset ADHD: Understanding the Evidence and Building Theoretical Frameworks (2017) (33)
Does childhood positive self-perceptual bias mediate adolescent risky behavior in youth from the MTA study? (2013) (33)
Auditory attention switching in hyperactive children (1991) (33)
The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults. (2016) (32)
Time-of-day effects in arousal: disrupted diurnal cortisol profiles in children with ADHD. (2012) (32)
Psychometric properties of Japanese version of the Swanson, Nolan, and Pelham, version-IV Scale-Teacher Form: A study of school children in community samples (2014) (32)
Effects of methylphenidate (Ritalin) on selective attention in hyperactive children (1979) (32)
Social Self Control, Externalizing Behavior, and Peer Liking Among Children with ADHD-CT: A Mediation Model. (2014) (32)
DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder (2009) (32)
Sequencing of sporadic Attention‐Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder (2017) (31)
Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency. (2015) (31)
Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. (2006) (31)
Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. (2020) (31)
Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. (2006) (31)
Chronic exposure to methylphenidate impairs appendicular bone quality in young rats. (2012) (31)
Recoding in a memory search task. (1972) (29)
Maternal ADHD Symptoms, Personality, and Parenting Stress: Differences Between Mothers of Children With ADHD and Mothers of Comparison Children (2018) (29)
Reducing Hyperactivity with a Feedback Actigraph: Initial Findings (2006) (29)
The action of enhancers can lead to addiction (2008) (28)
ADHD and manic symptoms: Diagnostic and treatment implications (2005) (28)
Liquid-chromatographic analysis for methylphenidate (Ritalin) in serum. (1979) (28)
Response to Commentary on the Multimodal Treatment Study of ADHD (MTA): Mining the Meaning of the MTA (2002) (27)
Long-term effects of adolescent-onset and persistent use of cannabis (2012) (27)
Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study (2018) (27)
Effect of Reinforcement on Facial Responsivity and Persistence in Children with Attention-Deficit Hyperactivity Disorder (1998) (27)
Response to Stimulant Medication across Six Measures of School-Related Performance in Children with ADHD and Disruptive Behavior (1992) (27)
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (26)
Maternal perspectives on the return of genetic results: Context matters (2013) (25)
Dissociation between spontaneously hypertensive (SHR) and Wistar–Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task (2010) (25)
Does multimodal treatment of ADHD decrease other diagnoses? (2005) (24)
Go/No Go task performance predicts cortical thickness in the caudal inferior frontal gyrus in young adults with and without ADHD (2016) (24)
Psychometric Properties of Teacher SKAMP Ratings From a Community Sample (2009) (24)
Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder (2008) (24)
Reaction times and evoked potentials as indicators of hemispheric differences for laterally presented name and physical matches. (1978) (24)
Lateralized deficits in covert shifts of visual attention in chronic and never-medicated schizophrenics compared to normal controls (1989) (23)
Task Specificity of Responses to Stimulant Drugs in Laboratory Tests (1979) (23)
Pemoline Pharmacokinetics and Long Term (1985) (23)
A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample (2019) (22)
Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene (2015) (21)
Intervention for preschoolers at risk for Attention-Deficit/Hyperactivity Disorder (ADHD): Service before diagnosis (2005) (21)
Can Attention Itself Be Trained? Attention Training for Children at Risk for ADHD (2007) (21)
Self-paced learning in children with attention deficit disorder with hyperactivity (1989) (21)
Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. (2005) (20)
A measure of ADHD-related classroom impairment based on targets for behavioral intervention (1997) (20)
Measuring strengths and weaknesses in dimensional psychiatry (2019) (19)
Genes and attention deficit hyperactivity disorder (2001) (18)
Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. (2002) (18)
Task force report: The appropriate role of clinical child psychologists in the prescribing of psychoactive medication for children. (1990) (17)
The SNAP Rating Scale for the Diagnosis of the Attention Deficit Disorder. (1981) (17)
Dopamine-transporter density in patients with ADHD (2000) (17)
A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants. (2020) (17)
Childhood ADHD and Involvement in Early Pregnancy: Mechanisms of Risk (2020) (17)
Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (Against). (2019) (16)
Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD. (2019) (16)
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning (2018) (16)
13 – Cognitive Deficit and Left-Handedness: A Cautionary Note (1980) (16)
Using long-acting stimulants: does it change ADHD treatment outcome? (2005) (15)
Part I: Executive Summary (2008) (15)
Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings? (2009) (15)
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (2016) (13)
Evaluation of individual subjects in the analog classroom setting: II. Effects of dose of amphetamine (Adderall). (1998) (13)
Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long-Term? (2019) (12)
Gestational and postnatal tobacco smoke exposure as predictor of ADHD, comorbid ODD/CD, and treatment response in the MTA (2005) (12)
ADHD Prevalence: Altitude or Sunlight? Better Understanding the Interrelations of Dopamine and the Circadian System (2018) (12)
Evaluation of learning disorders in children with a psychiatric disorder: An example from the Multimodal Treatment Study for ADHD (MTA Study). (2000) (12)
A Qualitative Analysis of Contextual Factors Relevant to Suspected Late-Onset ADHD (2019) (11)
Analysis of Pemoline in Serum by High Performance Liquid Chromatography: Clinical Application to Optimize Treatment of Hyperactive Children (1980) (11)
Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder (2017) (11)
Association between Dopamine D4 Receptor Polymorphism and Age Related Changes in Brain Glucose Metabolism (2013) (10)
Risk for emerging bipolar disorder, variants, and symptoms in children with attention deficit hyperactivity disorder, now grown up. (2015) (10)
Chapter 4 – PAIRED-ASSOCIATE LEARNING IN THE ASSESSMENT OF ADD-H CHILDREN (1989) (10)
Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). (2007) (10)
The neglected negative set. (1974) (10)
Prenatal stimulant exposure affects alerting and executive control in six and seven-year-olds (2000) (10)
CMAP ADHD and comorbid aggression algorithm [2] (2007) (9)
A liquid-chromatographic analysis for ritalinic acid [alpha-phenyl-alpha-(2-piperidyl) acetic acid] in serum. (1979) (9)
Attention Deficit Hyperactivity Disorder: Defining A Spectrum Disorder and Considering Neuroethical Implications (2011) (9)
Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states. (2000) (9)
Measures of cognitive functioning appropriate for use in pediatric psychopharmacological research studies. (1985) (8)
Research psychologists' roles in the genetic revolution. (2003) (8)
Depression and ADHD-Related Risk for Substance Use in Adolescence and Early Adulthood: Concurrent and Prospective Associations in the MTA (2019) (8)
Lessons From the 1918 Flu Pandemic: A Novel Etiologic Subtype of ADHD? (2020) (8)
Early substance use in the pathway from childhood attention-deficit/hyperactivity disorder (ADHD) to young adult substance use: Evidence of statistical mediation and substance specificity. (2019) (8)
Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews (2018) (8)
Aging as a Context for the Role of Inflammation in Depressive Symptoms (2021) (7)
Molecular genetics and attention in ADHD (2005) (7)
Adaptationism and molecular biology: An example based on ADHD (2002) (7)
Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity Disorder on Risk of Motor Vehicle Crashes: Results From the Multimodal Treatment Study of ADHD. (2020) (7)
Reply to: Attention-Deficit/Hyperactivity Disorder and Solar Irradiance: A Cloudy Perspective (2014) (7)
Turning Points in the Lives of Youth of With/Without ADHD: Are They Linked to Changes in Substance Use? (2018) (7)
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in The Multimodal Treatment Study of Children With ADHD: Developmental cascades and vicious cycles—CORRIGENDUM (2014) (6)
Dopamine and Glutamate in Attention Deficit Hyperactivity Disorder (2005) (6)
Predictive utility of childhood diagnosis of ICD-10 hyperkinetic disorder: adult outcomes in the MTA and effect of comorbidity (2018) (6)
Long-acting stimulants: development and dosing. (2005) (6)
Systematic dyskinesia examination of profoundly mentally retarded persons: cooperation and assessment. (1987) (6)
Risk of Bias and Quality of Evidence for Treatment of ADHD With Stimulant Medication (2018) (6)
Hyperkinetic disorders and attention deficit hyperactivity disorders (1997) (6)
Blood levels and tolerance to stimulants in ADDH children. (1986) (6)
Tardive dyskinesia in a developmentally disabled population: Manifestation during the initial stage of a minimal effective dose program. (1996) (6)
Developmental Aspects of Selective Orientation (1979) (6)
Hyperactive children: a study of the content analysis of their speech. (1984) (6)
Long-term outcomes in the Multimodal Treatment study of Children with ADHD (the MTA) (2018) (5)
Classification of types of tardive dyskinesia in a developmentally disabled population at a public residential facility (1993) (5)
Traditional and Innovative Assessment of Children with Attention Deficit Hyperactivity Disorder and Learning Disorders (2003) (5)
The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use (2018) (5)
Stimulant Effects on Persistence of Motor Performance of Hyperactive Children (1979) (5)
Use of a common software system for collaborative clinical research on attentional processes in schizophrenia and ADHD (1989) (5)
Adult substance use as a function of growth in peer use across adolescence and young adulthood in the context of ADHD: Findings from the MTA. (2019) (4)
The Effects of Stimulant Medication on Children with Attention Deficit Disorder. A Review of Reviews. Education of Children with Attention Deficit Disorder. (1992) (4)
Comparison of the Impact of OROS Methylphenidate HCI with Methylphenidate tid and Placebo on the Sleep of Children with ADHD (2000) (4)
Right visual field deficits in reaction time after invalid cues in chronic and never-medicated schizophrenics compared to normal controls (1989) (4)
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults. (2017) (4)
Food dyes and impairment of performance in hyperactive children. (1981) (4)
Genetics, altruism, and the National Children's Study (2008) (4)
An examination of the double-blind design in drug research with hyperactive children. (1978) (4)
How a regression artifact makes ICFs/MR look ineffective. (1998) (4)
Chorionic vascular structure and placental functional efficiency (beta) differ in high and low autism risk placental cohorts (2013) (3)
Transdermal methylphenidate more effective than placebo for treating ADHD (2008) (3)
Treatment with a controlled-release formulation of methylphenidate for attention-deficit/hyperactivity disorder: Onset and duration of effect (2002) (3)
Once-daily methylphenidate formulation: Impact on academic productivity and activity levels of children with attention-deficit/hyperactivity disorder (2002) (3)
The National Children's Study: Effectiveness of Household-based Recruitment (2011) (3)
Pemoline effects on children with ADHD (1996) (3)
Large-scale neocortical dynamic function and EEG (2000) (3)
73 COMPARING THE BEHAVIORAL EFFICTIVENESS OF TWO DRUCS WHICH HAVE DIFFERENT HALF LIVES (1978) (3)
Admissions to a public residential facility for individuals with developmental disabilities: Change in neuroleptic drug use and tardive dyskinesia (1994) (3)
Attention deficit disorder, volume IV : current concepts and emerging trends in attentional and behavioral disorders of childhood : proceedings of the Fourth High Point Hospital Symposium on ADD, held at Alton, Ontario, Canada (1989) (3)
Lack of correlation between placental gene expression and RNA integrity number (RIN) or time to collection (2014) (3)
The MTA at 8 (2009) (3)
Flawed Attention-Deficit/Hyperactivity Disorder Medication Comparison: In Reply (2004) (3)
DOES METHYLPHENIDATE INFLUENCE COGNITIVE PERFORMANCE (1997) (3)
The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. (2022) (2)
Methylphenidate improves the efficiency of the human brain (2008) (2)
Initiating Concerta(TM) (OROS® methylphenidate HCl) qd in children with attention-deficit hyperactivity disorder (2016) (2)
A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample - ERRATUM (2019) (2)
Measuring interhemispheric transfer time in man. (1977) (2)
Dopamine Reward Pathway in Adult ADHD—Reply (2010) (2)
The dopamine hypothesis of ADHD and brain response to stimulant medication. (2013) (2)
Exploring the biometal composition of human placentae from the U.S. National Children's Study (NCS) (2014) (2)
Re: New models for large prospective studies: is there a better way? (2013) (2)
Lateralized differences in reaction time in schizophrenic patients (1991) (2)
9.2 PATTERNS AND PREDICTORS OF STIMULANT MEDICATION USE FROM CHILDHOOD TO ADULTHOOD IN THE PROSPECTIVE LONG-TERM FOLLOW-UP OF THE MULTIMODAL TREATMENT STUDY OF ADHD (MTA) (2019) (1)
Addressing Incomplete Psychiatric Histories in Adult ADHD: Response to Agnew-Blais and Arseneault. (2018) (1)
Measuring Infant's Length with an Image (2018) (1)
Human placental study of genetics/genomic, environmental contaminant and morphology assessments from 12 U.S. Counties – Methods and results from the U.S. National Children’s Study (NCS) (2014) (1)
Large-scale neocortical dynamic function and EEG: Use of theory and methods in clinical research on children with Attention Deficit Hyperactivity Disorder (2000) (1)
Adipose Tissue Quantification in Human Neonates Using Water-Fat Separated MRI Permalink (2013) (1)
Balancing Strengths and Weaknesses in Dimensional Psychiatry (2017) (1)
3.26 Development of the Extended Strengths and Weaknesses Assessment of Normal Behavior Rating Scale (E-SWAN) (2017) (1)
53 A DOSE RESPONSE ANALYSIS OF THE EFFECT OF METHYLPHENIDATE (RITALIN) ON COCNITION OF HYPERACTIVE CHILDREN (1978) (1)
Letter to the Editor: Caution warranted when interpreting registry studies of medication. A response to Boland et al. (2020). (2022) (1)
Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate (2010) (1)
ASSESSMENT AND INTERVENTION FOR HYPERACTIVITY DISORDER IN THE SCHOOLS ATTENTION-DEFICIT/ (1999) (1)
DOES METHYLPHENIDATE INFLUENCE COGNITIVE PERFORMANCE?. AUTHORS' REPLY (1997) (1)
Memory comparison time for complex digit stimuli: The effect of number length (1981) (1)
The Importance of Scrutinizing Emergent ADHD Symptoms in Adults: Response to Chamberlain and Müller. (2018) (1)
Multiple Origins of Sex Differences in Attention Deficit Hyperactivity Disorder (2013) (1)
Maternal pre-pregnancy obesity and child ADHD symptoms, executive function and cortical thickness (2012) (1)
Teaching Strength Of Materials Using Web Based, Streaming Video, And Interactive Video Technologies (2002) (1)
Standardized videotaped procedure for evaluating withdrawal-emergent tardive dyskinesia in a public residential facility (1996) (1)
Meeting Reports: Adolescence - a Transition to Adulthood Proceedings of the 24th Aschauer Soiree, held at Jurata, Poland, November 5th 2016. (2017) (1)
Meeting Report: The Role of Beliefs and Perception on Body Size. Proceedings of the 26th Aschauer Soiree, Held at Aschauhof, Altenhof, Germany, May 26th, 2018. (2019) (1)
Stunted Growth. Proceedings of the 23rd Aschauer Soiree, Held at Aschauhof, Germany, November 7th 2015. (2016) (1)
Future Directions in the Holistic Treatment of Children with Learning and Attention Disorders: Concerns and Guidelines (2003) (1)
SAFETY OF COMBINED PHARMACOTHERAPHY (1997) (0)
35.2 Adult Outcomes of ICD-10 Hyperkinetic Disorder in the MTA and Effect of Comorbidity (2018) (0)
Erratum to “Mapping placental topology from 3D scans, the graphic display of variation in arborisation across gestation” [Placenta 34 (2013) A73–A74] (2014) (0)
Swanson, Nolan, and Pelham Rating Scale-IV--Teacher Form; Japanese Version (2017) (0)
The pediatric ADHD puzzle: Clinical criteria for diagnosis & management (2003) (0)
Parent Training Intervention for Preschool Children at Risk for ADHD: Effects on Child Behavior and Parent--Child Interactions: (694392007-001) (2007) (0)
Why Are Long-term Benefits of Stimulant Medication So Difficult to Detect? (2020) (0)
Impact of a Once-Daily OROS® Formulation of Methylphenidate on the Academic Productivity and Activity Levels of Children with ADHD (2001) (0)
21.1 Effects of Self-Selected Patterns of Stimulant Medication on Growth in the MTA: Longitudinal Analyses of Relative Physical Size From Childhood to Adulthood (2017) (0)
35.3 Adolescent Depression: Concurrent and Prospective Associations With Substance Use Risk in Adolescence and Young Adulthood in the MTA (2018) (0)
21.4 Turning Points in the Lives of Youth of With/Without Attention-Deficit/Hyperactivity Disorder: Are They Linked to Changes in Substance Use? (2017) (0)
22.2 MEDICATION USE AND LONG-TERM ADULT ADHD OUTCOME FROM THE MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD AND FOLLOW-UP (2020) (0)
Methylphenidate (OROS® Formulation) (2001) (0)
21.3 The MTA Qualitative Interview Study of Persistent and Non-Persistent Substance Use: Sample Selection, Demographic Characteristics, and Effects of Treatment and Natural History of the Disorder (2017) (0)
Childhood predictors of adult functional outcomes in the Multimodal Treatment study of ADHD (MTA) (2017) (0)
Final Program Forty Second Annual Meeting International Neuropsychological Society February 12–15, 2014 Seattle, Washington, USA (2014) (0)
Longitudinal Data From the 8-12 Year Assessments in the MTA Follow-Up: Effects of Assigned and Reported Medication Treatment on Symptom Severity and Height (2013) (0)
M)UCATION OF CHILDREN WITH ATTENTION DEFICIT DISORDER (2012) (0)
The Prospective 16-Year Follow-Up of the Multimodal Treatment Study of ADHD: Developmental Course of Symptom Severity and Impairment (2015) (0)
Multimodality Treatment of ADHD: Initial Findings of the MTA Study (1997) (0)
21.2 Substance Use Among Children With and Without Attention-Deficit/Hyperactivity Disorder Followed Prospectively Into Early Adulthood in the MTA (2017) (0)
35.4 Car Crashes in Drivers With Childhood and Adult ADHD: Results From the MTA (2018) (0)
S2045796019000283jra 1..9 (2019) (0)
Extended Strengths and Weaknesses Assessment of Normal Behavior (2020) (0)
Methylphenidate dose-response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial. (2023) (0)
Strengths and Weakness of ADHD Symptoms and Normal Behavior Scale (SWAN) (2005) (0)
USE OF A TOUCH SENSITIVE COMPUTER TABLET FOR THE QUANTITATIVE ANALYSIS OF HANDWRITING IN ATTENTION DEFICIT DISORDERED (ADD) CHILDREN (1984) (0)
Antiretroviral therapy in countries with low health expenditure (1998) (0)
DEFCT HYPERACTIVE DSORDER BY USING GT1 KNOCK-OUT MICE ASA NOVELADHD MOUSE MODEL (2017) (0)
Mapping placental topology from 3D scans, the graphic display of variation in arborisation across gestation (2013) (0)
"Information Processing as a Function of Speed versus Accuracy": Erratum. (1969) (0)
A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2013) (0)
Results of whole-genome analysis from National Children's Study (NCS) (2014) (0)
Never-medicated and chronic schizophrenics have right visual field deficits in exploratory eye movements (1989) (0)
The Genetic Latent Structure Model (1990) (0)
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task (2015) (0)
11.1 History of the Strengths and Weaknesses of Attention-Deficit/Hyperactivity Disorder—Symptom and Normal-Behavior Rating Scales: From 1990 to 2016 (2016) (0)
Strengths and Weaknesses of ADHD Symptoms and Normal Behaviors Rating Scale (2020) (0)
Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic- treated and untreated rats (2000) (0)
Title Fetal programming of body composition , obesity , and metabolic function : The role of intrauterine stress and stress biology Permalink (2012) (0)
Tissue Quantification in Human Neonates Using Water-Fat Separated (2013) (0)
6.74 SUBSTANCE USE ESCALATION INTO EARLY ADULTHOOD AMONG THE CHILDREN IN THE MTA (2016) (0)
F54. Methylation of the Dopamine Transporter Gene in Blood is Associated With Striatal Dopamine Transporter Availability in ADHD (2018) (0)
Cantwell's Approach to “Empiricism in Child Psychiatry” and Application to ADHD (2005) (0)
Age as a context for psychological sensitivity to inflammatory signaling in two depressive endophenotypes (2020) (0)
Bibliography FOR C HILD A ND A DOLESCENT P SYCHIATRY (2008) (0)
Growth, Nutrition and Economy (2021) (0)
The majority of variance in birthweight relative to placental weight (as beta=ln(PW)/ln(BW) is accounted for by detailed novel placental measures: implications for fetal origins work (2013) (0)
Part 1. Pediatric ADHD: Clinical Criteria for Diagnosis and Management (2004) (0)
The Effects of Stimulant Treatment of Child and Adolescent Growth: What Every Parent and Clinician Needs to Know (2021) (0)
Factor structure, measurement invariance, and scoring practices of the strengths and weaknesses of ADHD-symptoms and normal behavior. (2022) (0)
Meeting Report: Growth and Social Environment. Proceedings of the 25th Aschauer Soiree, held at Krobielowice, Poland, November 18th 2017. (2018) (0)
Severe deprivation in early childhood leads to permanent growth stunting: Longitudinal analysis of height trajectories from childhood-to-adulthood (2022) (0)
The role of belief and perceptions ob body size : Proceedings of the 26th Aschauer Soiree, Held at Aschauhof, Altenhof, Germany, May 26th, 2018 (2019) (0)
Growth and Social Environment (2018) (0)
' s response to reviews Efficacy of Two Once-Daily Methylphenidate Formulations Compared Across Dose Levels at Different Title : Times of the Day : Preliminary Indications from a Secondary Analysis of the COMACS Study Data (2004) (0)
Environmental Exposures during Pregnancy: US National Children's Study Formative Research Investigation (2014) (0)
The Role of Gene Encoding Variation of DRD4 in the Relationship between Inattention and Seasonal Daylight (2019) (0)
Evaluation of the Dopamine Hypothesis of ADHD with PET Brain Imaging (2010) (0)
35.1 Medication and Maturation in Girls and Boys With ADHD in the MTA (2018) (0)
Correction: Brown Adipose Tissue Quantification in Human Neonates Using Water-Fat Separated MRI (2014) (0)
Expression quantitative trait loci in placenta tissues from the national children’s study reveal developmental origins of human complex diseases (2014) (0)
DEXAMETHASONE SUPPRESSION TESTS (DST) IN ATTENTION DEFICIT DISORDERED (ADD) CHILDREN (1984) (0)
Reply: Safety of Combined Pharmacotheraphy (1997) (0)
Quantitative analysis of bisphenol a in human placentae from nine counties across the U.S.: National Children’s Study (NCS) (2014) (0)
Symposium (1987) (0)
Cmap adhd and comorbid aggression algorithm. Authors' reply (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With James M. Swanson?

James M. Swanson is affiliated with the following schools:

James M. Swanson's Academic­Influence.com Rankings

Why Is James M. Swanson Influential?

James M. Swanson's Published Works

Published Works

What Schools Are Affiliated With James M. Swanson?

James M. Swanson's AcademicInfluence.com Rankings